Provider review
AquaVita NextGen review
Tirzepatide has literally no price anywhere on the site
Semaglutide is $375 for a first month against a $499 list, with no ongoing rate published anywhere. The tirzepatide page carries the words "Transparent Pricing" and not a single dollar figure. Five states: CA, FL, TX, NV, AZ.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
AquaVita NextGen is genuinely a local medspa expanding into telehealth, with a real physical address and a named medical director — not a pure DTC operation. But its pricing transparency is thin: only a first-month semaglutide promo is published, and tirzepatide carries no price at all anywhere on the site. Its five-state footprint is honestly disclosed and precise, a real positive.
AquaVita NextGen is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You're located in one of the five covered states (CA, FL, TX, NV, AZ) and want an established local medspa
- You want a named medical director with emergency-medicine training
- You want both injectable and oral (ODT tablet) semaglutide options
Look elsewhere if
- You want to see a tirzepatide price before starting an intake — none exists anywhere on the site
- You want an ongoing semaglutide price, not just a first-month promotional figure
- You want a LegitScript or PCAB accreditation — neither was found anywhere
What it actually costs
What they advertise
Compounded semaglutide: $375 first month on aquavitanextgen.com.
What you actually pay, month to month
Ongoing monthly rate not published anywhere reachable; tirzepatide carries no price anywhere on the site.
The commitment trap
The $375 headline is a first-month-only promotional rate — the ongoing monthly price is never published anywhere.
Checked live on AquaVita NextGen's own site at https://aquavitanextgen.com/weight-loss/compounded-semaglutide/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what AquaVita NextGen bundles in, and what it does not.
Clinician consult
Licensed provider review.
Bloodwork / labs
Not published.
Follow-ups and dose changes
No cadence published.
Human support
Not published.
Injection supplies
Included in the price, at our last check.
Shipping
No terms published.
Pharmacy, labs and oversight
The pharmacy
Not named in any source we could reach.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
California, Florida, Texas, Nevada, and Arizona only.
The honest cons
The part they would rather you skipped
AquaVita NextGen's dedicated tirzepatide page contains zero dollar figures anywhere in its content — only "Transparent Pricing" marketing copy with no price ever actually shown, despite the drug being actively marketed and offered.
- Tirzepatide has no published price anywhere on the site
- Semaglutide's ongoing (non-first-month) price also isn't published
- No LegitScript or PCAB accreditation found
- Available in only five states
None of this is unique to AquaVita NextGen — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. AquaVita NextGen is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect AquaVita NextGen's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on AquaVita NextGen's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.